Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

8 May 2013 07:00

RNS Number : 1342E
ViaLogy PLC
08 May 2013
 



ViaLogy Contracted for QuantumRD Services in Ecuador

 

London, May, 8th 2013. ViaLogy PLC (VIY) announces it has signed a contract with a subsidiary of Singapore-based Gente Oil Global, Pte. Ltd. to apply its QuantumRD seismic interpretation technology on Ecuadorian properties in the Oriente Basin. ViaLogy will focus on reservoir discovery, delineation, and development in Napo sandstone formations that have proven too complicated to understand through conventional interpretation. Project results will support the planned drilling program.

The Oriente Basin of Ecuador is a prolific producing field with nearly 3billion barrels recovered over the past 20 years. It continues to be the focus of active exploration. QuantumRD will be used to analyze 3D seismic and accurately characterize recoverable reserves from stratigraphic sandstone traps within structures associated with Andean faulting. The lithology is complex, seismically and volcanically active and, prone to rapid areal and vertical changes in geological sequence. This project leverages some of the fluid imaging capabilities developed by ViaLogy in its work for supermajors to characterize stratigraphic reservoir assets that were below the vertical resolution of vintage seismic.

Gente Oil Global is comprised of experienced industry veterans with a proven track record of working successfully with Latin American governments to develop oil and gas resources. Combined, the management team has been responsible for the discovery of billions of barrels of oil and gas equivalent.

 

ViaLogy CEO Robert Dean said, "We are pleased to be working with Gente Oil Global to support their drilling program in the Oriente Basin of Ecuador. This gives us a chance to bring some of the QuantumRD capabilities we have optimized for reservoirs in highly tectonic basins where both structural and stratigraphic elements are in play. We see Latin America as a significant potential market for QuantumRD services".

 For further information:

ViaLogy PLC

Terry Bond, Chairman - UK & Europe +44 (0) 1235 834 734

 

Cantor Fitzgerald Europe (Nominated Advisor and Broker) +44 (0) 7894 7000

Mark Percy / Catherine Leftley (Corporate Finance)

Katie Ratner (Corporate Broking)

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery.

 

ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

 

About Gente Oil Global:

Gente Oil Global is a private international upstream oil and gas company focused on building an asset base across targeted regions of Latin America, North Africa, North America, and the Middle East. Chartered in Singapore in 2012 by a group of seasoned international oil and gas professionals, the company aims to capitalize on proven capabilities and contacts to create value through exploration, development and production of oil. Gente Oil Global is seeking oil exploration, production and development opportunities on the West Coast of South America such as Ecuador and Colombia, and is evaluating other opportunities globally. The primary goal of Gente Oil Global is to become a resource-rich oil producing company with multiple global assets. For more information on Gente Oil Global, visit www.genteoil.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSSSFFWFDSEDI
Date   Source Headline
14th Dec 20217:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSNotice of Half-year results
18th Nov 20217:00 amRNSDPYD screening recommended in Spain
28th Oct 20217:00 amRNSRanger® Technology to be presented at Labroots
26th Oct 20217:00 amRNSHalf-year Trading update
29th Sep 20217:00 amRNSResult of AGM
28th Sep 20213:00 pmRNSAGM update
28th Sep 20217:00 amRNSAGM Statement
15th Sep 20217:00 amRNSShare option awards
1st Sep 20217:00 amRNSISO 15189:2012 accreditation received
1st Sep 20217:00 amRNSNotice of AGM and Annual Report 2021
19th Aug 202112:04 pmRNSCOVID-19 Surge testing contract
11th Aug 20217:01 amRNSEarn-out Milestone, Issue of Equity & TVR
11th Aug 20217:00 amRNSAudited Final results&unaudited Q1 business update
6th Aug 20217:00 amRNSConfirmation of Results Date
23rd Jul 20217:00 amRNSNotice of Results
1st Jul 202111:09 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSSecond Strategic Partner for Coastal Genomics
18th Jun 20217:00 amRNSContract Award: DPYD testing kits for NHS Wales
17th Jun 20214:32 pmRNSExercise of Options
9th Jun 20217:00 amRNSMulti-year licence and supply agreement
21st May 20214:30 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSDistribution Partnership
18th May 20217:00 amRNSLaunch of IONA Care NIPT service offering
17th May 20217:00 amRNSFurther testing service agreement for MHC
29th Apr 20217:00 amRNSFull year Trading update
26th Apr 20217:00 amRNSFurther National Microbiology Framework awards
19th Apr 20211:21 pmRNSFurther National Microbiology Framework contract
19th Apr 20217:00 amRNSNational Framework contract award
12th Apr 20217:00 amRNSEarn-out Milestone, Issue of Equity & TVR
6th Apr 20212:43 pmRNSTesting service agreement with MyHealthCheckedplc
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:00 pmRNSCOVID-19 update
23rd Mar 20217:00 amRNSShare option exercises and awards
19th Mar 20217:00 amRNSTwin Pregnancy study published using IONA® Test
17th Mar 20217:00 amRNSAppointment of VP of Sales North America
11th Mar 20217:00 amRNSYourgene Genomic Services portfolio expansion
1st Mar 20217:00 amRNSFirst US Supply Agreement
22nd Feb 20217:00 amRNSPartnership with NPH
10th Feb 202110:51 amRNSCorrection: Director / PDMR Shareholding
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSTrading update
13th Jan 20217:00 amRNSDPYD screening recommended in Belgium
11th Jan 20217:00 amRNSClarigene® SARS-CoV-2 Product Update
8th Jan 20217:00 amRNSIssue of Share Options
24th Dec 20207:00 amRNSCOVID-19 update
17th Dec 20207:00 amRNSHalf-year Report
15th Dec 20207:00 amRNSNotice of Half-year Results
2nd Dec 20207:00 amRNSDPYD kits recommended by NHS England
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.